Other AML-associated somatic variants, such as NPM1, WT1, CEBPA, IDH1, NRAS and DNMT3A were detected for the FLT3-ITD patients, often in a patient-specific manner. This evidence concerns the gene DNMT3A and acute myeloid leukemia.